Inventors:
Charles A. Marotta - Cambridge MA
Ronald E. Majocha - Needham MA
Sudhir Agrawal - Shrewsbury MA
Assignee:
The General Hospital Corporation - Boston MA
International Classification:
C07H 2100
C12N 1511
Abstract:
The invention provides oligonucleotides that inhibit the expression of. beta. /A4 peptide of Alzheimer's disease and Down's syndrome, and further provides methods for reversing morphological changes caused in neuronal cells by. beta. /A4 peptide.